CYCLERION THERAPEUTICS, INC. Security Deposit Liability
CYCLERION THERAPEUTICS, INC. (CYCN) had Security Deposit Liability of $3.80 million as of 2020-12-31, per its 10-K filed 2022-02-24.
Discontinued › Balance Sheet › Liabilities
us-gaap:SecurityDepositLiability · last filed 2022-02-24
- 2020-12-31: Security Deposit Liability $3.80M.
- 2019-12-31: Security Deposit Liability $7.70M.
- 2019-04-01: Security Deposit Liability $7.70M.
| Period end | Security Deposit Liability |
|---|---|
| 2020-12-31 | $3.80M 10-K · filed 2022-02-24 |
| 2019-12-31 | $7.70M 10-K · filed 2021-02-25 |
| 2019-04-01 | $7.70M 10-Q · filed 2019-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |